NCT00600808View on ClinicalTrials.gov

Sustained Release Formulation of Somatropin (rDNA Origin)for Injection

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

June 30, 2006

Conditions

Growth Hormone Deficiency

Interventions

DRUG

BPLG-003

Sponsors

Lead Sponsor

BioPartners GmbH

Collaborators (1)

LG Life Sciences

All Listed Sponsors

collaborator

LG Life Sciences

INDUSTRY

lead

BioPartners GmbH

INDUSTRY

NCT00600808 - Sustained Release Formulation of Somatropin (rDNA Origin)for Injection | Biotech Hunter | Biotech Hunter